{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:02:41Z","timestamp":1788912161222,"version":"build-2803163510"},"reference-count":111,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Italian Ministry of Health","award":["GR-2016-02363749"],"award-info":[{"award-number":["GR-2016-02363749"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.msard.2018.09.035","type":"journal-article","created":{"date-parts":[[2018,10,2]],"date-time":"2018-10-02T11:25:53Z","timestamp":1538479553000},"page":"52-60","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Thymosins in multiple sclerosis and its experimental models: moving from basic to clinical application"],"prefix":"10.1016","volume":"27","author":[{"given":"Martina","family":"Severa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Giacomini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiana","family":"Rizzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilena Paola","family":"Etna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melania","family":"Cruciani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Garaci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Chopp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1606-2949","authenticated-orcid":false,"given":"Eliana Marina","family":"Coccia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.msard.2018.09.035_bib0001","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/ana.21117","article-title":"Environmental risk factors for multiple sclerosis. Part I: the role of infection.","volume":"61","author":"Ascherio","year":"2007","journal-title":"Ann. Neurol."},{"issue":"6","key":"10.1016\/j.msard.2018.09.035_bib0002","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/ana.21141","article-title":"Environmental risk factors for multiple sclerosis. Part II: noninfectious factors.","volume":"61","author":"Ascherio","year":"2007","journal-title":"Ann. Neurol."},{"issue":"8","key":"10.1016\/j.msard.2018.09.035_bib0003","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/S1567-5769(03)00024-9","article-title":"Thymosin beta(4) reduces lethality and down-regulates inflammatory mediators in endotoxin-induced septic shock","volume":"3","author":"Badamchian","year":"2003","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.msard.2018.09.035_bib0004","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1196\/annals.1415.046","article-title":"Identification and quantification of thymosin beta4 in human saliva and tears","volume":"1112","author":"Badamchian","year":"2007","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"8","key":"10.1016\/j.msard.2018.09.035_bib0005","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1001\/jamaneurol.2017.0676","article-title":"Interpreting lymphocyte reconstitution data from the pivotal phase 3 trials of Alemtuzumab","volume":"74","author":"Baker","year":"2017","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.msard.2018.09.035_bib0006","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1196\/annals.1415.024","article-title":"Thymosin beta-NB is the human isoform of rat thymosin beta15","volume":"1112","author":"Banyard","year":"2007","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"12","key":"10.1016\/j.msard.2018.09.035_bib0007","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1038\/nm1296-1322","article-title":"Thymosin beta 15: a novel regulator of tumor cell motility upregulated in metastatic prostate cancer","volume":"2","author":"Bao","year":"1996","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.msard.2018.09.035_bib0008","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1002\/ana.21939","article-title":"Abnormal B-cell cytokine responses a trigger of T-cell-mediated disease in MS?","volume":"67","author":"Bar-Or","year":"2010","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.msard.2018.09.035_bib0009","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.clim.2011.04.005","article-title":"Treatment of multiple sclerosis with anti-CD20 antibodies","volume":"142","author":"Barun","year":"2012","journal-title":"Clin. Immunol."},{"issue":"2-3","key":"10.1016\/j.msard.2018.09.035_bib0010","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0165-5728(90)90063-S","article-title":"Prothymosin-alpha enhances HLA-DR antigen expression on monocytes from patients with multiple sclerosis","volume":"27","author":"Baxevanis","year":"1990","journal-title":"J. Neuroimmunol."},{"issue":"1","key":"10.1016\/j.msard.2018.09.035_bib0011","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.immuni.2009.11.009","article-title":"CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients","volume":"32","author":"Blair","year":"2010","journal-title":"Immunity"},{"issue":"7016","key":"10.1016\/j.msard.2018.09.035_bib0012","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/nature03000","article-title":"Thymosin beta4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair","volume":"432","author":"Bock-Marquette","year":"2004","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.msard.2018.09.035_bib0013","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1093\/intimm\/dxm097","article-title":"Thymosin alpha1 activates the TLR9\/MyD88\/IRF7-dependent murine cytomegalovirus sensing for induction of anti-viral responses in vivo","volume":"19","author":"Bozza","year":"2007","journal-title":"Int. Immunol."},{"issue":"5","key":"10.1016\/j.msard.2018.09.035_bib0014","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1007\/BF02327082","article-title":"Receptors for thymosin fraction V on rat thymic lymphocytes","volume":"38","author":"Brelinska","year":"1982","journal-title":"Experientia"},{"key":"10.1016\/j.msard.2018.09.035_bib0015","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.neuropharm.2014.06.004","article-title":"Beneficial effects of thymosin beta4 on spinal cord injury in the rat","volume":"85","author":"Cheng","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.msard.2018.09.035_bib0016","first-page":"1","article-title":"Thymosin beta4 as a restorative\/regenerative therapy for neurological injury and neurodegenerative diseases","author":"Chopp","year":"2015","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.msard.2018.09.035_bib0017","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1196\/annals.1415.051","article-title":"Development of thymosin beta4 for treatment of patients with ischemic heart disease","volume":"1112","author":"Crockford","year":"2007","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.msard.2018.09.035_bib0018","first-page":"71","article-title":"Oligodendrocyte, astrocyte, and microglia crosstalk in myelin development, damage, and repair","volume":"4","author":"Domingues","year":"2016","journal-title":"Front. Cell Dev. Biol."},{"issue":"10","key":"10.1016\/j.msard.2018.09.035_bib0019","doi-asserted-by":"crossref","first-page":"6092","DOI":"10.4049\/jimmunol.178.10.6092","article-title":"Distinct effector cytokine profiles of memory and naive human B cell subsets and implication in multiple sclerosis","volume":"178","author":"Duddy","year":"2007","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.msard.2018.09.035_bib0020","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1620\/tjem.161.303","article-title":"Effect of thymic hormones on induction of experimental allergic encephalomyelitis in old mice","volume":"161","author":"Endoh","year":"1990","journal-title":"Tohoku J. Exp. Med."},{"issue":"4","key":"10.1016\/j.msard.2018.09.035_bib0021","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/BF02527717","article-title":"Inflammation in EAE: role of chemokine\/cytokine expression by resident and infiltrating cells","volume":"21","author":"Eng","year":"1996","journal-title":"Neurochem. Res."},{"issue":"9","key":"10.1016\/j.msard.2018.09.035_bib0022","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/S1474-4422(08)70192-3","article-title":"B cells and multiple sclerosis","volume":"7","author":"Franciotta","year":"2008","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.msard.2018.09.035_bib0023","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1196\/annals.1415.044","article-title":"Thymosin alpha 1: from bench to bedside","volume":"1112","author":"Garaci","year":"2007","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"Suppl 1","key":"10.1016\/j.msard.2018.09.035_bib0024","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1517\/14712598.2015.1017466","article-title":"Historical review on thymosin alpha1 in oncology: preclinical and clinical experiences","volume":"15","author":"Garaci","year":"2015","journal-title":"Expert Opin. Biol. Ther."},{"issue":"7","key":"10.1016\/j.msard.2018.09.035_bib0025","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1002\/eji.201243212","article-title":"IFN-beta therapy modulates B-cell and monocyte crosstalk via TLR7 in multiple sclerosis patients","volume":"43","author":"Giacomini","year":"2013","journal-title":"Eur. J. Immunol."},{"issue":"Suppl 1","key":"10.1016\/j.msard.2018.09.035_bib0026","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.1517\/14712598.2015.1019460","article-title":"Dual effect of Thymosin alpha 1 on human monocyte-derived dendritic cell in vitro stimulated with viral and bacterial toll-like receptor agonists","volume":"15","author":"Giacomini","year":"2015","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.msard.2018.09.035_bib0027","article-title":"Thymosin-alpha1 expands deficient IL-10-producing regulatory B cell subsets in relapsing-remitting multiple sclerosis patients","author":"Giacomini","year":"2017","journal-title":"Mult. Scler."},{"issue":"1","key":"10.1016\/j.msard.2018.09.035_bib0028","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2567.2003.01616.x","article-title":"Anti-inflammatory effects in the skin of thymosin-beta4 splice-variants","volume":"109","author":"Girardi","year":"2003","journal-title":"Immunology"},{"key":"10.1016\/j.msard.2018.09.035_bib0029","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1196\/annals.1415.045","article-title":"History of the discovery of the thymosins","volume":"1112","author":"Goldstein","year":"2007","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"1","key":"10.1016\/j.msard.2018.09.035_bib0030","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1517\/14712598.2012.634793","article-title":"Thymosin beta4: a multi-functional regenerative peptide. Basic properties and clinical applications.","volume":"12","author":"Goldstein","year":"2012","journal-title":"Expert Opin. Biol. Ther."},{"issue":"4","key":"10.1016\/j.msard.2018.09.035_bib0031","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1517\/14712598.4.4.559","article-title":"Thymosins: chemistry and biological properties in health and disease","volume":"4","author":"Goldstein","year":"2004","journal-title":"Expert Opin. Biol. Ther."},{"issue":"Suppl 1","key":"10.1016\/j.msard.2018.09.035_bib0032","doi-asserted-by":"crossref","first-page":"S139","DOI":"10.1517\/14712598.2015.1011617","article-title":"Advances in the basic and clinical applications of thymosin beta4","volume":"15","author":"Goldstein","year":"2015","journal-title":"Expert Opin. Biol. Ther."},{"issue":"2","key":"10.1016\/j.msard.2018.09.035_bib0033","article-title":"Blood B cell and regulatory subset content in multiple sclerosis patients","volume":"2","author":"Habib","year":"2015","journal-title":"J. Mult. Scler. (Foster City)"},{"key":"10.1016\/j.msard.2018.09.035_bib0034","doi-asserted-by":"crossref","first-page":"257","DOI":"10.3389\/fneur.2015.00257","article-title":"Remyelination therapy in multiple sclerosis","volume":"6","author":"Harlow","year":"2015","journal-title":"Front. Neurol."},{"key":"10.1016\/j.msard.2018.09.035_bib0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.vh.2016.04.009","article-title":"Structures of thymosin proteins","volume":"102","author":"Hoch","year":"2016","journal-title":"Vitam. Horm."},{"issue":"6","key":"10.1016\/j.msard.2018.09.035_bib0036","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.cellbi.2006.01.009","article-title":"Thymosin beta4 and AcSDKP inhibit the proliferation of HL-60 cells and induce their differentiation and apoptosis","volume":"30","author":"Huang","year":"2006","journal-title":"Cell Biol. Int."},{"issue":"3","key":"10.1016\/j.msard.2018.09.035_bib0037","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S1357-2725(00)00087-X","article-title":"Beta-Thymosins, small acidic peptides with multiple functions","volume":"33","author":"Huff","year":"2001","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"3","key":"10.1016\/j.msard.2018.09.035_bib0038","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/j.1365-2893.2005.00633.x","article-title":"The efficacy and safety of thymosin alpha-1 in Japanese patients with chronic hepatitis B; results from a randomized clinical trial","volume":"12","author":"Iino","year":"2005","journal-title":"J. Viral Hepat."},{"issue":"4","key":"10.1016\/j.msard.2018.09.035_bib0039","doi-asserted-by":"crossref","first-page":"388","DOI":"10.3109\/08923973.2015.1069837","article-title":"Thymosin alpha1 plus routine treatment inhibit inflammatory reaction and improve the quality of life in AECOPD patients","volume":"37","author":"Jia","year":"2015","journal-title":"Immunopharmacol. Immunotoxicol."},{"issue":"11","key":"10.1016\/j.msard.2018.09.035_bib0040","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1097\/00005072-199711000-00003","article-title":"Identification of post-mitotic oligodendrocytes incapable of remyelination within the demyelinated adult spinal cord","volume":"56","author":"Keirstead","year":"1997","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"1","key":"10.1016\/j.msard.2018.09.035_bib0041","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.1038\/s41598-017-03782-x","article-title":"Thymosin beta-4 regulates activation of hepatic stellate cells via hedgehog signaling","volume":"7","author":"Kim","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.msard.2018.09.035_bib0042","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/bs.vh.2016.04.003","article-title":"Immune Modulation with Thymosin Alpha 1 Treatment","volume":"102","author":"King","year":"2016","journal-title":"Vitam. Horm."},{"issue":"1\u20132","key":"10.1016\/j.msard.2018.09.035_bib0043","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jneuroim.2011.08.019","article-title":"Reduction in IL-10 producing B cells (Breg) in multiple sclerosis is accompanied by a reduced naive\/memory Breg ratio during a relapse but not in remission","volume":"239","author":"Knippenberg","year":"2011","journal-title":"J. Neuroimmunol."},{"issue":"5","key":"10.1016\/j.msard.2018.09.035_bib0044","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1177\/1352458514566419","article-title":"Promoting remyelination in multiple sclerosis: current drugs and future prospects","volume":"21","author":"Kremer","year":"2015","journal-title":"Mult. Scler."},{"issue":"6","key":"10.1016\/j.msard.2018.09.035_bib0045","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.17219\/acem\/32026","article-title":"Thymosin beta as an actin-binding protein with a variety of functions","volume":"25","author":"Kuzan","year":"2016","journal-title":"Adv. Clin. Exp. Med."},{"issue":"2","key":"10.1016\/j.msard.2018.09.035_bib0046","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1750-3639.2007.00064.x","article-title":"The immunopathology of multiple sclerosis: an overview","volume":"17","author":"Lassmann","year":"2007","journal-title":"Brain Pathol."},{"issue":"5","key":"10.1016\/j.msard.2018.09.035_bib0047","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s00418-016-1529-1","article-title":"Thymosin beta4 overexpression regulates neuron production and spatial distribution in the developing avian optic tectum","volume":"147","author":"Lever","year":"2017","journal-title":"Histochem. Cell Biol."},{"issue":"310","key":"10.1016\/j.msard.2018.09.035_bib0048","doi-asserted-by":"crossref","first-page":"310ra166","DOI":"10.1126\/scitranslmed.aab4176","article-title":"Proinflammatory GM-CSF-producing B cells in multiple sclerosis and B cell depletion therapy","volume":"7","author":"Li","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.msard.2018.09.035_bib0049","article-title":"MiR-200a mediates protection of thymosin beta 4 in cardiac microvascular endothelial cells as a novel mechanism under hypoxia-reoxygenation injury","author":"Li","year":"2017","journal-title":"J. Cell. Biochem."},{"issue":"8","key":"10.1016\/j.msard.2018.09.035_bib0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0103984","article-title":"Proteomic profiling in multiple sclerosis clinical courses reveals potential biomarkers of neurodegeneration","volume":"9","author":"Liguori","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.msard.2018.09.035_bib0051","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1186\/s12879-016-1823-5","article-title":"The efficacy of thymosin alpha1 as immunomodulatory treatment for sepsis: a systematic review of randomized controlled trials","volume":"16","author":"Liu","year":"2016","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.msard.2018.09.035_bib0052","article-title":"MicroRNA-146a promotes oligodendrogenesis in stroke","author":"Liu","year":"2016","journal-title":"Mol. Neurobiol."},{"issue":"6","key":"10.1016\/j.msard.2018.09.035_bib0053","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.cell.2010.08.012","article-title":"Function of miR-146a in controlling Treg cell-mediated regulation of Th1 responses","volume":"142","author":"Lu","year":"2010","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.msard.2018.09.035_bib0054","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1517\/14728222.2010.499127","article-title":"Thymus hormones as prospective anti-inflammatory agents","volume":"14","author":"Lunin","year":"2010","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.msard.2018.09.035_bib0055","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/bs.vh.2016.04.010","article-title":"Thymosin beta4: roles in development, repair, and engineering of the cardiovascular system","volume":"102","author":"Marks","year":"2016","journal-title":"Vitam. Horm."},{"issue":"6","key":"10.1016\/j.msard.2018.09.035_bib0056","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.immuni.2014.10.016","article-title":"Interleukin-10-producing plasmablasts exert regulatory function in autoimmune inflammation","volume":"41","author":"Matsumoto","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.msard.2018.09.035_bib0057","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2217\/fmb-2016-0125","article-title":"Thymosin alpha 1 and HIV-1: recent advances and future perspectives","volume":"12","author":"Matteucci","year":"2017","journal-title":"Future Microbiol."},{"issue":"10","key":"10.1016\/j.msard.2018.09.035_bib0058","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1093\/intimm\/dxv038","article-title":"The expanding family of regulatory B cells","volume":"27","author":"Mauri","year":"2015","journal-title":"Int. Immunol."},{"issue":"1","key":"10.1016\/j.msard.2018.09.035_bib0059","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1471-4159.2008.05570.x","article-title":"The life, death, and replacement of oligodendrocytes in the adult CNS","volume":"107","author":"McTigue","year":"2008","journal-title":"J. Neurochem."},{"issue":"2","key":"10.1016\/j.msard.2018.09.035_bib0060","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.clim.2014.09.011","article-title":"Unaltered regulatory B-cell frequency and function in patients with multiple sclerosis","volume":"155","author":"Michel","year":"2014","journal-title":"Clin. Immunol."},{"issue":"2","key":"10.1016\/j.msard.2018.09.035_bib0061","doi-asserted-by":"crossref","first-page":"705","DOI":"10.4049\/jimmunol.176.2.705","article-title":"A case for regulatory B cells","volume":"176","author":"Mizoguchi","year":"2006","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.msard.2018.09.035_bib0062","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.4049\/jimmunol.176.3.1712","article-title":"Immunity and tolerance to Aspergillus involve functionally distinct regulatory T cells and tryptophan catabolism","volume":"176","author":"Montagnoli","year":"2006","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.msard.2018.09.035_bib0063","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0192-0561(97)00005-2","article-title":"Biodistribution of synthetic thymosin beta 4 in the serum, urine, and major organs of mice","volume":"19","author":"Mora","year":"1997","journal-title":"Int. J. Immunopharmacol."},{"issue":"2","key":"10.1016\/j.msard.2018.09.035_bib0064","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.neuroscience.2010.05.017","article-title":"Thymosin beta4 improves functional neurological outcome in a rat model of embolic stroke","volume":"169","author":"Morris","year":"2010","journal-title":"Neuroscience"},{"issue":"9","key":"10.1016\/j.msard.2018.09.035_bib0065","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.4155\/fmc.11.72","article-title":"Intracellular and extracellular cytokine-like functions of prothymosin alpha: implications for the development of immunotherapies","volume":"3","author":"Mosoian","year":"2011","journal-title":"Future Med. Chem."},{"issue":"4","key":"10.1016\/j.msard.2018.09.035_bib0066","first-page":"213","article-title":"Intensive suppression of experimental allergic encephalomyelitis (EAE) by serum thymic factor and therapeutic implication for multiple sclerosis","volume":"52","author":"Nagai","year":"1982","journal-title":"Jpn. J. Exp. Med."},{"issue":"7321","key":"10.1016\/j.msard.2018.09.035_bib0067","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/nature09614","article-title":"Myelination and support of axonal integrity by glia","volume":"468","author":"Nave","year":"2010","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.msard.2018.09.035_bib0068","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1365-2990.1982.tb00308.x","article-title":"In-situ characterization of mononuclear cell infiltrates in lesions of multiple sclerosis","volume":"8","author":"Nyland","year":"1982","journal-title":"Neuropathol. Appl. Neurobiol."},{"issue":"1","key":"10.1016\/j.msard.2018.09.035_bib0069","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/cei.12833","article-title":"Serum thymosin alpha 1 levels in patients with chronic inflammatory autoimmune diseases","volume":"186","author":"Pica","year":"2016","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.msard.2018.09.035_bib0070","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.ejphar.2015.03.042","article-title":"Animal models of Multiple Sclerosis","volume":"759","author":"Procaccini","year":"2015","journal-title":"Eur. J. Pharmacol."},{"issue":"10","key":"10.1016\/j.msard.2018.09.035_bib0071","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/nri2163","article-title":"IDO and regulatory T cells: a role for reverse signalling and non-canonical NF-kappaB activation","volume":"7","author":"Puccetti","year":"2007","journal-title":"Nat. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.msard.2018.09.035_bib0072","first-page":"336","article-title":"Multiple sclerosis: II. Effects of prothymosin alpha on the autologous and allogeneic MLR in patients with multiple sclerosis.","volume":"70","author":"Reclos","year":"1987","journal-title":"Clin. Exp. Immunol."},{"issue":"9899","key":"10.1016\/j.msard.2018.09.035_bib0073","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/S0140-6736(13)61810-3","article-title":"Cell therapy for multiple sclerosis: an evolving concept with implications for other neurodegenerative diseases","volume":"382","author":"Rice","year":"2013","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.msard.2018.09.035_bib0074","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/0008-8749(85)90051-6","article-title":"Receptors for thymosin alpha 1 on mouse thymocytes","volume":"91","author":"Rinaldi Garaci","year":"1985","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.msard.2018.09.035_bib0075","doi-asserted-by":"crossref","DOI":"10.1038\/icb.2016.55","article-title":"Interferon-beta therapy specifically reduces pathogenic memory B cells in Multiple Sclerosis patients by inducing a FAS-mediated apoptosis","author":"Rizzo","year":"2016","journal-title":"Immunol. Cell Biol."},{"issue":"11","key":"10.1016\/j.msard.2018.09.035_bib0076","doi-asserted-by":"crossref","first-page":"4232","DOI":"10.1182\/blood-2003-11-4036","article-title":"Thymosin alpha 1 activates dendritic cells for antifungal Th1 resistance through toll-like receptor signaling","volume":"103","author":"Romani","year":"2004","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.msard.2018.09.035_bib0077","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1182\/blood-2006-02-004762","article-title":"Thymosin alpha1 activates dendritic cell tryptophan catabolism and establishes a regulatory environment for balance of inflammation and tolerance","volume":"108","author":"Romani","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.msard.2018.09.035_bib0078","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1196\/annals.1415.002","article-title":"Thymosin alpha1: an endogenous regulator of inflammation, immunity, and tolerance","volume":"1112","author":"Romani","year":"2007","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.msard.2018.09.035_bib0079","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1749-6632.2012.06716.x","article-title":"Jack of all trades: thymosin alpha1 and its pleiotropy","volume":"1269","author":"Romani","year":"2012","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"5","key":"10.1016\/j.msard.2018.09.035_bib0080","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/nm.4305","article-title":"Thymosin alpha1 represents a potential potent single-molecule-based therapy for cystic fibrosis","volume":"23","author":"Romani","year":"2017","journal-title":"Nat. Med."},{"issue":"17","key":"10.1016\/j.msard.2018.09.035_bib0081","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.2174\/0929867324666170518110033","article-title":"Prothymosin alpha: an alarmin and more","volume":"24","author":"Samara","year":"2017","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.msard.2018.09.035_bib0082","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/bs.vh.2016.04.008","article-title":"Prothymosin alpha and immune responses: are we close to potential clinical applications?","volume":"102","author":"Samara","year":"2016","journal-title":"Vitam. Horm."},{"issue":"12","key":"10.1016\/j.msard.2018.09.035_bib0083","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1002\/glia.22400","article-title":"Thymosin beta 4 mediates oligodendrocyte differentiation by upregulating p38 MAPK","volume":"60","author":"Santra","year":"2012","journal-title":"Glia"},{"issue":"28","key":"10.1016\/j.msard.2018.09.035_bib0084","doi-asserted-by":"crossref","first-page":"19508","DOI":"10.1074\/jbc.M113.529966","article-title":"Thymosin beta4 up-regulation of microRNA-146a promotes oligodendrocyte differentiation and suppression of the Toll-like proinflammatory pathway","volume":"289","author":"Santra","year":"2014","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.msard.2018.09.035_bib0085","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/jnc.13394","article-title":"Thymosin beta 4 up-regulates miR-200a expression and induces differentiation and survival of rat brain progenitor cells","volume":"136","author":"Santra","year":"2016","journal-title":"J. Neurochem."},{"issue":"15","key":"10.1016\/j.msard.2018.09.035_bib0086","doi-asserted-by":"crossref","first-page":"13286","DOI":"10.1074\/jbc.M213005200","article-title":"Prothymosin alpha is processed to thymosin alpha 1 and thymosin alpha 11 by a lysosomal asparaginyl endopeptidase","volume":"278","author":"Sarandeses","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.msard.2018.09.035_bib0087","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1750-3639.2004.tb00049.x","article-title":"Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis","volume":"14","author":"Serafini","year":"2004","journal-title":"Brain Pathol."},{"key":"10.1016\/j.msard.2018.09.035_bib0088","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1749-6632.2012.06707.x","article-title":"Thymosin alpha1 as a stimulatory agent of innate cell-mediated immune response","volume":"1270","author":"Serafino","year":"2012","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"4","key":"10.1016\/j.msard.2018.09.035_bib0089","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.exer.2006.12.004","article-title":"Thymosin beta 4 suppression of corneal NFkappaB: a potential anti-inflammatory pathway","volume":"84","author":"Sosne","year":"2007","journal-title":"Exp. Eye Res."},{"issue":"10","key":"10.1016\/j.msard.2018.09.035_bib0090","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.3109\/07357900902849640","article-title":"Advances in thymosin beta10 research: differential expression, molecular mechanisms, and clinical implications in cancer and other conditions","volume":"27","author":"Sribenja","year":"2009","journal-title":"Cancer Invest."},{"key":"10.1016\/j.msard.2018.09.035_bib0091","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1749-6632.2012.06680.x","article-title":"Thymosin alpha1 continues to show promise as an enhancer for vaccine response","volume":"1270","author":"Tuthill","year":"2012","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"1","key":"10.1016\/j.msard.2018.09.035_bib0092","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/jnc.13963","article-title":"Prothymosin alpha-deficiency enhances anxiety-like behaviors and impairs learning\/memory functions and neurogenesis","volume":"141","author":"Ueda","year":"2017","journal-title":"J. Neurochem."},{"key":"10.1016\/j.msard.2018.09.035_bib0093","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1749-6632.2012.06675.x","article-title":"Prothymosin alpha plays multifunctional cell robustness roles in genomic, epigenetic, and nongenomic mechanisms","volume":"1269","author":"Ueda","year":"2012","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"Suppl 1","key":"10.1016\/j.msard.2018.09.035_bib0094","doi-asserted-by":"crossref","first-page":"S187","DOI":"10.1517\/14712598.2015.1009891","article-title":"The role of thymosin-beta4 in kidney disease","volume":"15","author":"Vasilopoulou","year":"2015","journal-title":"Expert Opin. Biol. Ther."},{"issue":"3","key":"10.1016\/j.msard.2018.09.035_bib0095","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0090-1229(85)90092-3","article-title":"Immunoglobulin G, A, and M\u2013clonal restriction in multiple sclerosis cerebrospinal fluid and serum\u2013analysis by two-dimensional electrophoresis","volume":"35","author":"Walsh","year":"1985","journal-title":"Clin. Immunol. Immunopathol."},{"issue":"3","key":"10.1016\/j.msard.2018.09.035_bib0096","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.nbd.2012.08.002","article-title":"Thymosin beta4 promotes the recovery of peripheral neuropathy in type II diabetic mice","volume":"48","author":"Wang","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.msard.2018.09.035_bib0097","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/173656","article-title":"Therapeutic benefit of extended thymosin beta4 treatment is independent of blood glucose level in mice with diabetic peripheral neuropathy","volume":"2015","author":"Wang","year":"2015","journal-title":"J. Diabetes Res."},{"issue":"8","key":"10.1016\/j.msard.2018.09.035_bib0098","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1002\/cne.23004","article-title":"Thymosin beta4 induces folding of the developing optic tectum in the chicken (Gallus domesticus)","volume":"520","author":"Wirsching","year":"2012","journal-title":"J. Comp. Neurol."},{"issue":"Pt 2","key":"10.1016\/j.msard.2018.09.035_bib0099","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/brain\/awt333","article-title":"Thymosin beta 4 gene silencing decreases stemness and invasiveness in glioblastoma","volume":"137","author":"Wirsching","year":"2014","journal-title":"Brain"},{"issue":"6","key":"10.1016\/j.msard.2018.09.035_bib0100","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1084\/jem.184.6.2271","article-title":"Experimental autoimmune encephalomyelitis induction in genetically B cell-deficient mice","volume":"184","author":"Wolf","year":"1996","journal-title":"J. Exp. Med."},{"issue":"4","key":"10.1016\/j.msard.2018.09.035_bib0101","first-page":"215","article-title":"Experimental allergic encephalomyelitis in guinea pigs. Influence of thymosin fraction V on the disease.","volume":"7","author":"Woyciechowska","year":"1985","journal-title":"J. Neuroimmunol."},{"issue":"3","key":"10.1016\/j.msard.2018.09.035_bib0102","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/jcbfm.2014.207","article-title":"Brain endothelial miR-146a negatively modulates T-cell adhesion through repressing multiple targets to inhibit NF-kappaB activation","volume":"35","author":"Wu","year":"2015","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.msard.2018.09.035_bib0103","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/4578230","article-title":"miRNAs Participate in MS pathological processes and its therapeutic response","volume":"2016","author":"Wu","year":"2016","journal-title":"Mediators Inflamm."},{"issue":"5","key":"10.1016\/j.msard.2018.09.035_bib0104","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.3171\/2012.1.JNS111729","article-title":"Neuroprotective and neurorestorative effects of thymosin beta4 treatment initiated 6 hours after traumatic brain injury in rats","volume":"116","author":"Xiong","year":"2012","journal-title":"J. Neurosurg."},{"issue":"41","key":"10.1016\/j.msard.2018.09.035_bib0105","doi-asserted-by":"crossref","first-page":"6715","DOI":"10.3748\/wjg.v12.i41.6715","article-title":"Efficacy of thymosin alpha-1 and interferon alpha in treatment of chronic viral hepatitis B: a randomized controlled study","volume":"12","author":"You","year":"2006","journal-title":"World J. Gastroenterol."},{"issue":"4","key":"10.1016\/j.msard.2018.09.035_bib0106","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1016\/j.neuroscience.2009.09.054","article-title":"Neurological functional recovery after thymosin beta4 treatment in mice with experimental auto encephalomyelitis","volume":"164","author":"Zhang","year":"2009","journal-title":"Neuroscience"},{"issue":"6","key":"10.1016\/j.msard.2018.09.035_bib0107","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1159\/000445578","article-title":"Function of thymosin beta-4 in ethanol-induced microglial activation","volume":"38","author":"Zhang","year":"2016","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.msard.2018.09.035_bib0108","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.nbd.2016.01.010","article-title":"Thymosin beta4 promotes oligodendrogenesis in the demyelinating central nervous system","volume":"88","author":"Zhang","year":"2016","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.msard.2018.09.035_bib0109","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.neuroscience.2017.02.029","article-title":"MiR-146a promotes remyelination in a cuprizone model of demyelinating injury","volume":"348","author":"Zhang","year":"2017","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/j.msard.2018.09.035_bib0110","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13058-016-0785-2","article-title":"Thymosin beta 10 is a key regulator of tumorigenesis and metastasis and a novel serum marker in breast cancer","volume":"19","author":"Zhang","year":"2017","journal-title":"Breast Cancer Res."},{"issue":"17","key":"10.1016\/j.msard.2018.09.035_bib0111","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1097\/WNR.0000000000000463","article-title":"Thymosin beta4 inhibits microglia activation through microRNA 146a in neonatal rats following hypoxia injury","volume":"26","author":"Zhou","year":"2015","journal-title":"Neuroreport"}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034818303584?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034818303584?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:43:42Z","timestamp":1761900222000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034818303584"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":111,"alternative-id":["S2211034818303584"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2018.09.035","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thymosins in multiple sclerosis and its experimental models: moving from basic to clinical application","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2018.09.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}